Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: Cell surface exposure

International Immunopharmacology

Volumn 20, Issue 2, 2014, Pages 359-365

  Korbelik, Mladen ^a   Banáth, Judit ^a   Sun, Jinghai ^a   Canals, Daniel ^b   Hannun, Yusuf A ^b   Separovic, Duska ^c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b Stony Brook Medicine   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Ceramide; Damage associated molecular patterns; Photodynamic therapy; Sphingosine 1 phosphate; Squamous cell carcinoma

Indexed keywords

CERAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE; LYSOPHOSPHOLIPID; PATTERN RECOGNITION RECEPTOR; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; INTRACELLULAR SIGNALING; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL LINE; ANALOGS AND DERIVATIVES; ANIMAL; C3H MOUSE; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; CELL SEPARATION; DISEASE MODEL; HEAD AND NECK NEOPLASMS; METABOLISM; PHOTOCHEMOTHERAPY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MEMBRANE; CELL SEPARATION; CERAMIDES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C3H; PHOTOCHEMOTHERAPY; RECEPTORS, PATTERN RECOGNITION; SPHINGOSINE;

EID: 84899075598     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.03.016     Document Type: Article

References (35)

1. P. Matzinger The danger model: a renewed sense of self Science 296 2002 301 305
2. S. Seong, and P. Matzinger Hydrophobicity: an ancient damage-associated molecular pattern that initiates immune responses Nat Rev Immunol 4 2004 469 478
3. G. Srikrishna, and H.H. Freeze Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer Neoplasia 11 2009 615 628
4. A.D. Garg, D. Nowis, J. Golab, P. Vandenabeele, D.V. Krysko, and P. Agostinis Immunogenic cell death DAMPs and anticancer therapeutics: an emerging amalgamation Biochim Biophys Acta 2010 1805 53 71
5. I. Cecic, B. Stott, J. Sun, and M. Korbelik Relevance of innate immunity recognition of altered self in the induction of host response associated with photodynamic therapy Recent Res Dev Cancer 6 2004 153 161
6. O. Krysko, T. Løve Aaes, C. Bachert, P. Vandenabeele, and D.V. Krysko Many faces of DAMPs in cancer therapy Cell Death Dis 4 2013 e631 10.1038/cddis.2013.156
7. P. Agostinis, K. Berg, K.A. Cengel, T.H. Foster, A.W. Girotti, and S.O. Gollnick et al. Photodynamic therapy of cancer: an update CA Cancer J Clin 61 2011 250 281
8. M. Korbelik PDT-associated host response and its role in the therapy outcome Lasers Surg Med 38 2006 500 508
9. A.D. Garg, S. Martin, J. Golab, and P. Agostinis Danger signalling during cell death: origins, plasticity and regulation Cell Death Differ 21 2014 26 38
10. M. Korbelik, W. Zhang, and S. Merchant Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release Cancer Immunol Immunother 60 2011 1431 1437
11. D. Khurana, E.A. Martin, J.L. Kasperbauer, B.W. O'Malley Jr., D.R. Salomao, and L. Chen et al. Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy Head Neck 23 2001 899 906
12. J. Gioanni, J.-L. Fischel, J.-C. Lambert, F. Demard, C. Mazeau, and E. Zanghellini et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment Eur J Cancer Clin Oncol 24 1988 1445 1455
13. B.X. Wu, C.F. Snook, M. Tani, E.E. Büllesbach, and Y.A. Hannun Large-scale purification and characterization of recombinant Pseudomonas ceramidase: regulation by calcium J Lipid Res 48 2007 600 608
14. D. Canals, R.W. Jenkins, P. Roddy, M.J. Henandez-Corbacho, L.M. Obeid, and Y.A. Hannun Differential effects of ceramide and sphingosine-1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane J Biol Chem 285 2010 32476 32485
15. T.T. Puck, and P.I. Marcus Action of X-rays on mammalian cells J Exp Med 103 1956 636 666
16. M. Korbelik, W. Zhang, and D. Separovic Monitoring ceramide and sphingosine-1-phosphate levels in cancer cells and macrophages from tumours treated by photodynamic therapy Photochem Photobiol Sci 11 2012 779 784
17. D.J. Dougherty, C.A. Allen, and N.M. Hogg Applications of immunological techniques to the study of tumor-host relationship D.M. Weir, L.A. Herzenberg, C. Blackwell, L.A. Herzenberg, Handbook of Experimental Immunology vol. 4 1986 Blackwell Oxford 125.1 125.12
18. M. Obeid, S. Tesniere, F. Ghiringhelli, G.M. Fimia, L. Apetoh, and J.-L. Perfettini et al. Calreticulin exposure dictates the immunogenicity of cancer cell death Nat Med 13 2007 54 61
19. S. Chatterjee Neutral sphingomyelinase: past, present and future Chem Phys Lipids 102 1999 79 96
20. A.H. Merrill Jr., and E. Wang Enzymes of ceramide biosynthesis Methods Enzymol 209 1992 427 437
21. F.H. Sarkar, Y. Li, Z. Wang, and D. Kong NF-κB signaling pathway and its therapeutic implications in human diseases Int Rev Immunol 27 2008 293 319
22. M. Korbelik, J. Sun, and I. Cecic Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response Cancer Res 65 2005 1018 1026
23. M. Korbelik Complement upregulation in photodynamic therapy-treated tumors: role of Toll-like receptor pathway and NFκB Cancer Lett 281 2009 232 238
24. L.A. Cowart, Z. Szulc, A. Bielawska, and Y.A. Hannun Structural determinants of sphingolipid recognition by commercially available anti-ceramide antibodies J Lipid Res 43 2002 2042 2048
25. A. Kimura, T. Ohmori, Y. Kashiwakura, R. Ohkawa, S. Madoiwa, and J. Mimuro et al. Antagonism of sphingosine 1-phorphate receptor-2 enhances migration of neural progenitor cells toward an area of brain infarction Stroke 39 2008 3411 3417
26. G. Canti, P. Franco, O. Marelli, L. Ricci, and A. Nicolin Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210) Cancer Res 44 1984 1551 1556
27. D. Bressoud, V. Jomini, and R.M. Tyrell Dark induction of haem oxygenase messenger RNA by haematoporphyrin derivative and zinc phthalocyanine; agents for photodynamic therapy J Photochem Photobiol B Biol 14 1992 311 318
28. M. Korbelik, W. Zhang, K.M. Saw, Z.M. Szulc, A. Bielawska, and D. Separovic Cationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors J Photochem Photobiol B Biol 126 2013 72 77
29. A.D. Garg, D.V. Krysko, P. Vandenabeele, and P. Agostinis The emergence of phox-ER stress induced immunogenic apoptosis Oncoimmunology 1 2012 786 788
30. T. Verfaillie, A.D. Garg, and P. Agostinis Targeting ER stress induced apoptosis and inflammation in cancer Cancer Lett 332 2013 249 264
31. S. Marchal, L. Bezdatnaya, and F. Guillemin Modality of cell death induced by Foscan-based photodynamic treatment in human colon adenocarcinoma cell line HT29 Biochemistry (Mosc) 69 2004 45 49
32. P.G. Calzavara-Pinton, M. Venturini, and R. Sala Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology J Eur Acad Dermatol Venereol 21 2007 293 302
33. G.M. Strub, M. Maceyka, N.C. Hait, S. Milstien, and S. Spiegel Extracellular and intracellular actions of sphingosine-1-phosphate Adv Exp Med Biol 688 2010 141 155
34. H. Fischer, P. Ellström, K. Ekström, L. Gustafsson, M. Gustafsson, and C. Svanborg Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4 Cell Microbiol 9 2007 1239 1251
35. W.L. Holland, B.T. Bikman, L.P. Wang, G. Yuguang, K.M. Sargent, and S. Bulchand et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice J Clin Invest 121 2011 1858 1870